Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Radiation Oncology
•
Medical Oncology
•
Lymphoma
•
Hematology
What is the role of radiation consolidation after chemotherapy for residual splenic involvement in follicular lymphoma?
Answer from: Radiation Oncologist at Academic Institution
Recommend 3000 cGy in 15 fractions
Sign in or Register to read more
808
Related Questions
How would you treat an elderly male with history of mantle cell lymphoma who relapsed after chemoimmunotherapy and cBTKi w/ multiple co-morbidities including CKD and CHF w/ low EF?
What is your approach to managing follicular lymphoma with central nervous system involvement?
For plasmablastic lymphoma responsive to treatment except for a recurrent lymph node eroding into a vertebral body at the end of chemotherapy, would you cover the entire vertebral body in your CTV, or treat only the involved lymph node with a margin?
What post-protocol therapies did patients on the BRUIN trial in CLL receive, and how did these therapies impact outcomes?
How would you approach fertility preservation in a young patient with DLBCL requiring R-CHOP?
How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?
How would you treat a tDLBCL originally treated with R-CHOP who relapses with DLBCL 15 years after the original diagnosis?
Given the data from SWOG 1826 suggesting that Nivo-AVD is likely the preferred regimen for advanced Hodgkin lymphoma patients, are there scenarios where alternative regimens may still be preferred?
Does tolerance of prior BTKi therapy or specific agent used (e.g., ibrutinib, acalabrutinib) influence your starting dose of pirtobrutinib?
How would you manage a stage IE Burkitt lymphoma with stable disease after three cycle of DA-R-EPOCH?